The March 2018 edition of Tablets & Capsules magazine features an article written by experts at Halo Pharmaceuticals on the topic of fixed-dose combination products.You will notice in the feature photo that Bosch equipment is the platform in use.
Here is an excerpt —
Fixed-dose combination (FDC) drug products are a safe and cost-effective way for pharmaceutical companies to extend patent protections and improve patient adherence to drug therapy, but developing FDCs can be challenging.
To read the whole article, click here.
Photo credit — Tablets & Capsules